Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles1 certified filing for “Business Leadership Development (BuiLD) Associate” (Management Analysts) in NY: $170k–$170k, median $170k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles
- 1 certified filing for “Business Leadership Development (BuiLD) Associate” (Management Analysts) in NY: $170k–$170k, median $170k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Build our future together:
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Associate Director, Publications to lead the development and execution of aligned dissemination plans across clinical, HEOR/RWE, PKPD, and disease state publications. You will participate in cross functional meetings, monthly core publication team meetings, present at regular strategic meetings and workshops and relevant alliance partner meetings needed to build and regularly refine publication plans ensuring cross functional partners are aligned and informed.
This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.
Where & when:
• Location: Warren, NJ or Sleepy Hollow, NY
• Work model/flexibility: On-site, 4 days/week
Discover your role :
• Partner in the development of scientific, clinical, and health-outcomes publications, ensuring accuracy, readability, and timely delivery
• Shape the scientific narrative and lexicon behind our data, translating statistical findings into clear strategic communication
• Guide cross-functional and alliance-wide publication teams through collaborative discussion, independent research, and strategic alignment
• Oversee budget, forecasting, and resource allocation, tracking expenditures and flagging issues early
• Partner across functions to identify gaps and opportunities that continually evolve our publication strategy
• Accurate and timely reporting of post-publications metrics, compliant maintenance of records in the Publication Management Tool (e.g., iEnvision), vendor and budget management.
• Manage timelines, quality, and efficiency across publication activities
• Track and report post-publication metrics, maintaining compliant, well-documented records
• Review and submit manuscripts, abstracts, and presentations in partnership with cross-functional colleagues
This role requires :
• PhD/PharmD/MD with 5+ years of experience in medical affairs, publications, or scientific communications
• Proven track record of managing publication plans, ideally with experience in Immunology related therapeutic areas.
• Experience managing external agency partners and publication vendors, including budget oversight, SOW management, and performance management.
• Working knowledge of Good Publication Practice (GPP 22), ICMJE, OIG, PhRMA code, Sunshine Act, and copyright/permission guidelines
• Experience collaborating within multi-disciplinary teams
• Alliances management experience preferred
Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.
Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experie
Apply on employer site ↗